Pharmena S.A. (WSE:PHR)
3.160
+0.010 (0.32%)
Jul 3, 2026, 5:00 PM CET
Pharmena Market Cap
Pharmena has a market cap or net worth of 35.2 million as of July 2, 2026. Its market cap has decreased by -7.06% in one year.
Market Cap
35.20M
Enterprise Value
35.12M
Revenue
1.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.16
Market Cap Chart
Since August 25, 2008, Pharmena's market cap has decreased from 171.99M to 35.20M, a decrease of -79.54%. That is a compound annual growth rate of -8.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 35.20M | 21.54% |
| Dec 30, 2025 | 28.96M | -32.11% |
| Dec 30, 2024 | 42.66M | -46.06% |
| Dec 29, 2023 | 79.08M | 26.79% |
| Dec 30, 2022 | 62.37M | -29.20% |
| Dec 30, 2021 | 88.10M | -10.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Captor Therapeutics Spolka Akcyjna | 475.23M |
| Syn2bio | 427.90M |
| Ryvu Therapeutics | 350.50M |
| BIOTON | 340.88M |
| Synthaverse | 217.08M |
| Molecure | 124.44M |
| Mabion | 117.66M |
| Poltreg | 108.86M |